Christopher Schott
JPMorgan Chase & Co, Research Division
Good morning, everybody. I’m Chris Schott from JPMorgan. It’s my pleasure to be introducing Zoetis today. From the company, we have a presentation from CEO, Kristin Peck, and we’ll have Wetteny Joseph, company’s CFO, available for Q&A. So with that, Kristin, happy New Year and looking forward to the presentation.
Kristin Peck
CEO & Director
Well, thank you, Chris, and welcome to everyone. It is great to be back at JPMorgan, and I’m excited to share today how Zoetis is defining the next era in animal health, powered by our industry-leading innovation, our science-to-scale model and our disciplined execution. Now everyone’s favorite slide, some housekeeping before we get started.
Today’s remarks will include forward-looking statements and non-GAAP financials. For more information on these risks as well as the reconciliation to our GAAP financials, please visit our Investor Relations website and click on today’s presentation.
As Chris mentioned, today, I am joined by our Chief Financial Officer, Wetteny Joseph. And together, we are excited to share how Zoetis’ momentum and capabilities will shape the future of animal health.
So let me get started on the slides now. We are excited to share — where am I now? Okay. We’re excited today to really highlight the essential animal health industry, which has got very strong sectoral tailwinds, which we’ll discuss. The industry is projected to grow to $90 billion over the next 10 years, really led by tailwinds in both companion animal and livestock.
Next, we’ll really highlight the science-to-scale model at
